(3 years, 1 month ago)
Commons ChamberThere will be no question of discriminating in any way between vaccinated and unvaccinated children. Vaccinations are voluntary and will remain so.
My hon. Friend acknowledges there is a small hazard with the vaccine programme, which is why there is one jab for these younger children. Will he confirm that all families will have access to their trusted family GP to get advice and understanding on the hazards before they are expected to make a decision on this important matter?
The best way for parents and families to make that decision is through the tried and tested process of the school age vaccination programme, and through schools sharing information and having a consent form that parents have to sign and return before the vaccination programme is scheduled.
(3 years, 1 month ago)
Commons ChamberUrgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
We have spent a lot of time, energy and resource on ensuring that those with medical exemptions, who have underlying medical conditions, were prioritised in both category 4 and 6 of phase 1 of the vaccination programme, as the hon. Member will recall. The Joint Committee on Vaccination and Immunisation has gone further for the immunosuppressed. As I said earlier, there will be exemptions from this particular set of rules for people who, for whatever reason, cannot be vaccinated or cannot have a test for medical conditions.
Will my hon. Friend confirm that the duration of these passports, whether they are passed by the Government or it is done by a vote, would only last as long as it is considered that the United Kingdom was in a pandemic state, not an endemic state, in terms of the disease? Will he also set out when that transition happens so that we can judge and understand it for ourselves?
I am grateful for my hon. Friend’s thoughtful question. There is great difficulty with knowing at what stage we feel confident that the virus has transitioned from pandemic to endemic. We have now entered a period of equilibrium with the virus because of the success of the vaccination programme. The upward pressure on infections is obviously schools going back. The downward pressure on infections will be the booster programme and mitigating policies like the one we are debating. The Government certainly do not see this as a long-term power grab to restrict people’s liberties.
(3 years, 2 months ago)
Commons ChamberMy hon. Friend has heard me say today that no one embarks on this lightly, and it is not in the Prime Minister’s DNA to curtail people’s freedoms. It is purely so that we can have sustainable continuation of an open economy that we would introduce such programmes. I do not know—if anyone claims otherwise, they are foolhardy or foolish—when we can definitely say that the virus has transitioned from pandemic to endemic status.
Medical autonomy on vaccinations has been removed from workers in care home settings, so when will medical autonomy be removed from nurses, doctors and consultants in the NHS?
In the original consultation on social care conditions of deployment, which we eventually introduced and have discussed today, part of the feedback was that we should consult on the wider health service, including frontline healthcare workers. By the way, I commend both social care and healthcare workers because the majority of them have come forward to be vaccinated. Indeed, more than 94% of frontline healthcare workers have had both doses. We will bring forward a consultation on this, because there is a duty of care for those looking after vulnerable people in hospitals or care homes to be protected against covid.
(3 years, 3 months ago)
Commons ChamberI am grateful for the right hon. Member’s question. I would just remind him that the Treasury has put £407 billion to work to shelter the economy and people’s livelihoods and, of course, protect jobs. He raises a number of important questions about looking at other countries. As I said earlier, these are all difficult decisions, but I think we are making the right, cautious decision as we transition—I hope—and see this virus move from pandemic to endemic status.
Can my right hon. Friend give me a better sense of the scope of how the covid ID card may be used in the future? Would it apply to the London marathon? Would it apply to political gatherings: would someone need an ID card to attend a political gathering, whether supportive of or in opposition to the Government? Could he please rule out its use in educational settings such as sixth-form colleges or universities, which should be excluded? The focus now is on young adults, and the ID card should not be a passport to education or a denial of education.
On the last question, I can certainly give my hon. Friend the assurance that in education or in any public buildings this will not be applicable. As to things such as the transport system or essential retail, that is our very strong commitment. Look, I keep repeating this message, but we know what we need to do. Part of what we are learning from the data here and around the world is about trying to work with industries, such as the nightclub industry and sports bodies, to make sure that we reopen fully as safely as possible and continue to be open. The worst thing for any industry or for any sport is to open and then, sadly, to have to shut down again, as people have seen around the world.
(3 years, 5 months ago)
Commons ChamberUrgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
The hon. Lady asked a similar question last week, and Professor Harnden of the JCVI said that the problem with antibody testing is what it really tells us. I will happily ask the question again on her behalf of the JCVI. Suffice it to say that on 17 May we put out guidance to employers saying that those who are shielding and immunocompromised should be allowed to work from home if they need to.
Will my hon. Friend confirm that the Government’s position on the coronavirus pandemic is that it is still a question of life and death, that communications are vital in this effort and that compliance follows confidence, which in turn follows competence? Will he confirm when these local lockdown measures were agreed with the leadership at Bolton Council and when the Prime Minister formally agreed to this updated guidance being imposed?
My hon. Friend will recall that the Prime Minister addressed this issue on 14 May.
(3 years, 10 months ago)
Commons ChamberThe local restrictions support grants, additional restriction grants and Christmas support payments are all available now for businesses through their local authority. I know that the Secretary of State takes these businesses very seriously. Throughout this whole process, since back in March, he made sure that all his Ministers talked to local government to make sure that we do get those payments out promptly.
The Government have invested approximately £1 billion through two life sciences sector deals, helping to generate significant industry investment in the UK. Last year the industry had a turnover in the UK of £80.7 billion.
The life sciences sector is a truly international endeavour, as can be so clearly seen with the recent vaccine research efforts. With worries in the sector about our ongoing relationship with European countries and the European Union, would my hon. Friend confirm that the concerns of the life sciences sector are of paramount importance in the ongoing negotiations?
Clearly, the UK’s relationship with the EU is subject to ongoing negotiations, but as we leave the EU the life sciences sector will be supported through the life sciences sector deals that I mentioned, and a new, innovative regulatory framework. The Medicines and Healthcare Products Regulatory Agency has proven itself globally to be one of the finest regulators in the world, and new international regulatory collaborations are on the way too.